Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Science (London, England : 1979)|August 13, 2008
Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissueJeremy F L Cobbold, Quentin M Anstee, Robert D Goldin, et al.
Hepatology (Baltimore, Md.)|September 16, 2010
Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor functionAlexandra Milona, Bryn M Owen, Jeremy F L Cobbold, et al.
Ebiomedicine|January 15, 2019
PYY plays a key role in the resolution of diabetes following bariatric surgery in humansClaudia Guida, Sam D Stephen, Michael Watson, et al.
Cell Metabolism|January 13, 2026
Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at nightThomas Marjot, Kieran Smith, Felix Westcott, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 21, 2017
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot studyJeremy F L Cobbold, Stephen Atkinson, Julian R Marchesi, et al.
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Medcomm|November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter StudyJing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Pageof 3